New eczema drug tested in major Real-World trial
NCT ID NCT07276620
Summary
This study is testing how well an already-approved eczema medication called ivarmacitinib works in everyday practice. It will enroll 1,000 teens and adults with moderate-to-severe atopic dermatitis to measure how quickly itching improves and skin clears up. The research also aims to collect safety data and see how different maintenance treatment plans affect whether the eczema comes back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.